• May 12, 2022 all day
  • Location: Royal Society of Chemistry, London Burlington House, Piccadilly, London W1J 0BA
  • Latest Activity: Apr 1

Antibody drug conjugates (ADCs) are an exciting and challenging new area of research and are becoming ever more popular across the industry with more than 100 ADCs reported in the clinic. The targeted nature of the molecules makes them extremely suitable for delivering toxic molecules to the biological target.
However the complexity of the molecules and the lack of regulatory experience increases the complexity in discovery and development across all disciplines.
This symposium brings together experts from across the industry to share their knowledge and learning for an engaging and exciting meeting.

Dr Stuart Dunn - Labcorp
Dr Richard Easton - BioPharmaSpec
Dr Colin McKee - Sterling Pharma
Dr Christiane Niederlaender - Parexel
Prof Miraz Rahman - Kings College London
Dr Gary Watts - Abzena

EVENT LINK: https://www.jpag.org/154

VENUE LINK: www.rsc.org/locations-contacts/

WEB LINK: https://www.jpag.org/

ORGANISED BY: Joint Pharmaceutical Analysis Group

SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry

CONTACT: Hon Events Secretary JPAG, events@jpag.org

E-mail me when people leave their comments –

You need to be a member of CAMS-UK to add comments!


To have your event listed here contact us: